Position in MRK
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$364,940
-$27,205 QoQ
Shares Held
2,840
-12.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#2,971
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CHELSEA COUNSEL CO holds $9,679,558 across 10 Drug Manufacturers - General names. MRK ranks #6 (3.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
17,904 | $4,547,078 | |
| 2 | AMGN |
Amgen Inc
|
8,954 | $3,242,422 | |
| 3 | GSK |
GSK plc
|
9,360 | $490,651 | |
| 4 | PFE |
Pfizer Inc
|
20,000 | $481,600 | |
| 5 | LLY |
ELI LILLY & Co
|
351 | $420,999 | |
| 6 | MRK |
Merck & Co., Inc.
This page
|
2,840 | $364,940 | |
| 7 | SNY |
Sanofi
|
1,845 | $78,707 | |
| 8 | ABBV |
AbbVie Inc.
|
114 | $28,686 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $364,940 | 2,840 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $392,145 | 3,260 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $343,147 | 3,260 | Shares | Sole | 2026-02-24 | |
| 2025-09-30 | $294,594 | 3,510 | Shares | Sole | 2025-11-25 | |
| 2025-06-30 | $304,766 | 3,850 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $1,743,139 | 19,420 | Shares | Sole | 2025-05-22 | |
| 2024-12-31 | $1,931,901 | 19,420 | Shares | Sole | 2025-02-27 | |
| 2024-09-30 | $2,574,973 | 22,675 | Shares | Sole | 2024-11-21 | |
| 2024-06-30 | $2,818,307 | 22,765 | Shares | Sole | 2024-11-21 | |
| 2024-03-31 | $3,011,230 | 22,821 | Shares | Sole | 2024-06-17 | |
| 2023-12-31 | $2,749,593 | 25,221 | Shares | Sole | 2024-02-21 | |
| 2023-09-30 | $3,008,301 | 29,221 | Shares | Sole | 2023-11-22 | |
| 2023-06-30 | $3,371,811 | 29,221 | Shares | Sole | 2023-11-22 | |
| 2023-03-31 | $3,108,822 | 29,221 | Shares | Sole | 2023-05-19 | |
| 2022-12-31 | $3,230,974 | 29,121 | Shares | Sole | 2023-02-23 | |
| 2022-09-30 | $2,464,840 | 28,621 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $3,117,101 | 34,190 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $2,808,571 | 34,230 | Shares | Sole | 2022-05-24 | |
| 2021-12-31 | $2,633,120 | 34,357 | Shares | Sole | 2022-05-23 | |
| 2021-09-30 | $2,580,554 | 34,357 | Shares | Sole | 2022-02-10 | |
| 2021-06-30 | $2,690,608 | 34,597 | Shares | Sole | 2022-02-10 | |
| 2021-03-31 | $2,667,083 | 34,597 | Shares | Sole | 2022-02-10 | |
| 2020-12-31 | $2,838,212 | 34,697 | Shares | Sole | 2022-03-08 | |
| 2020-09-30 | $2,937,260 | 35,410 | Shares | Sole | 2022-05-06 | |
| 2020-06-30 | $2,738,333 | 35,411 | Shares | Sole | 2022-05-06 | |
| 2020-03-31 | $2,590,721 | 33,672 | Shares | Sole | 2020-06-12 | |
| No filing history on record for this holder in this stock. | ||||||